3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
9
Completed
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
289
Carcinoma, Non-Small-Cell Lung
236
Neoplasms
189
Prostatic Neoplasms
188
Lung Neoplasms
147
Multiple Myeloma
143
Neoplasm Metastasis
106
Colorectal Neoplasms
95
Melanoma
93
Ovarian Neoplasms
87
Leukemia, Myeloid, Acute
79
Lymphoma
73
Leukemia, Lymphocytic, Chronic, B-Cell
73
Brain Neoplasms
69
Pancreatic Neoplasms
67
Carcinoma, Renal Cell
64
Hematologic Neoplasms
60
Squamous Cell Carcinoma of Head and Neck
58
Carcinoma, Hepatocellular
58
Urinary Bladder Neoplasms
57
Lymphoma, Non-Hodgkin
57
Glioblastoma
55
Triple Negative Breast Neoplasms
54
Head and Neck Neoplasms
53
Recurrence
51
Lymphoma, Follicular
50
Uterine Cervical Neoplasms
49
Glioma
46
Small Cell Lung Carcinoma
45
Sarcoma
45
Interventions
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neuroectodermal Tumors, Primitive
×
90 days
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled